VALENTINE-PTCL01
VALENTINE-PTCL01: Primary Results of Phase II Trial of Valemetostat Tosylate in Patients With Relapsed/Refractory Peripheral T-Cell Lymphomas

Released: December 11, 2023

Activity

Progress
1
Course Completed